Advil Liqui-Gel Mini Recalled for Missing Safety Warnings
Glaxosmithkline is recalling specific lots of Advil Liqui-Gel Mini because the Drug Facts Panel lacks required safety warning information.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to a labeling error (missing safety warnings). Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries or illnesses are typically scored as Moderate (2).
Plain-English summary
Glaxosmithkline Consumer Healthcare Holdings is recalling 4,104 bottles of Advil Liqui-Gel Mini 160+20+20 CT (e-commerce). The recall involves specific lots identified by Batch/Lot # 0198FR and # 3188FRB, both with an expiration date of 10/31/2020. The product was distributed throughout the United States, including Puerto Rico.
The recall was initiated because certain lots do not include required safety warning information in the Drug Facts Panel. This labeling deficiency means the packaging lacks specific safety warnings or the Rx legend required by regulations.
Consumers who have purchased these specific lots should stop using the product and contact the manufacturer or their point of purchase for a refund or replacement. The recall is classified as FDA Class II, indicating a reasonable probability of temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Advil Liqui-Gel Mini 160+20+20 CT (e-commerce) NDC # 0573-1715-59 SKU# F00573171559 (original lot # R53074) Co-packaged Batch/Lot # 0198FR & 3188FRB
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings
- Hazard
- Affected units
- 4,104
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch/Lot # Lot # 0198FR
- original lot # R53074
- exp. date 10/31/2020 Lot # 3188FRB
- exp. date 10/31/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Glaxosmithkline Consumer Healthcare Holdings under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Glaxosmithkline Consumer Healthcare Holdings
See all →- ModerateChildren's Robitussin DM Recalled for Missing Dosing Cup Graduations
FDA (Drugs) · 2020-07-08
- ModerateChildren's Dimetapp Cold & Cough Recalled for Missing Dosing Cup Graduations
FDA (Drugs) · 2020-07-08
- ModerateGaviscon Antacid Recalled for Missing Magnesium Safety Warning
FDA (Drugs) · 2020-06-24
- ModerateGaviscon Extra Strength Liquid Antacid Recalled for Missing Magnesium Warning
FDA (Drugs) · 2020-06-24
- ModerateGaviscon Liquid Antacid Recalled for Missing Magnesium Safety Warning
FDA (Drugs) · 2020-06-24
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02